Internal Medicine, Hematology & Oncology · Montebello, CA
NPI
1730379728
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
101 E Beverly Blvd, Suite 200
Montebello, CA, 90640
Phone (323) 278-4400
Groups this clinician bills Medicare through
Medicare paid, 2024
$551K
26,248 services
Medicare patients, 2024
247
Average age 72
Drug cost, 2024
$3.0M
662 prescriptions
Company payments, 2025
$3,713
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravin M Rupani was code 99214 (office e&m - established), 296 times for 120 patients. In total Ravin M Rupani billed 26,248 services in 70 codes, and Medicare paid $551K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 296 | 120 | $100.88 | $30K |
| 99442 Telephone Services | Office | 181 | 92 | $48.60 | $8,797 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 149 | 24 | $93.66 | $14K |
| 96372 Injection Administration | Office | 120 | 18 | $12.52 | $1,502 |
| 99232 Hospital E&M - Subsequent | Facility | 113 | 24 | $65.72 | $7,426 |
| 99213 Office E&M - Established | Office | 109 | 77 | $67.53 | $7,361 |
| 99233 Hospital E&M - Subsequent | Facility | 103 | 30 | $98.92 | $10K |
| 36415 Venipuncture Blood Collection | Office | 88 | 38 | $8.65 | $761 |
| 99215 Office E&M - Established | Office | 70 | 28 | $145.86 | $10K |
| 99223 Hospital E&M - Initial | Facility | 43 | 38 | $144.58 | $6,217 |
| 96127 Behavioral Health Services | Office | 40 | 35 | $4.22 | $169 |
| 96367 Intravenous Infusion, Hydration | Office | 38 | 11 | $26.08 | $991 |
| 96365 Intravenous Infusion, Hydration | Office | 28 | 15 | $58.30 | $1,632 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 26 | 14 | $0.61 | $15.79 |
| 99443 Telephone Services | Office | 22 | 12 | $79.96 | $1,759 |
By year: 2022 $712K for 35,012 services; 2023 $609K for 25,940 services; 2024 $551K for 26,248 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 88 | 38 | $8.65 | $761 |
Medicare prescription drug claims, 2024
In 2024, the drug Ravin M Rupani prescribed most often to Medicare patients was Eliquis (Apixaban), with 43 prescriptions and refills. In total Ravin M Rupani wrote 662 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 43 | 47 | Under 11 | $27K |
| Anastrozole Generic | 39 | 94 | 20 | $906 |
| Ondansetron Hcl Generic | 38 | 38 | 23 | $1,794 |
| Trazimera Trastuzumab-Qyyp | 34 | 34 | Under 11 | $86K |
| Promacta Eltrombopag Olamine | 23 | 23 | Under 11 | $250K |
| Perjeta Pertuzumab | 22 | 22 | Under 11 | $135K |
| Hydroxyurea Generic | 21 | 38 | Under 11 | $291 |
| Xtandi Enzalutamide | 19 | 19 | Under 11 | $264K |
| Letrozole Generic | 18 | 42 | Under 11 | $259 |
| Tagrisso Osimertinib Mesylate | 15 | 15 | Under 11 | $248K |
| Calquence Acalabrutinib Maleate | 13 | 13 | Under 11 | $198K |
| Prednisone Generic | 13 | 13 | Under 11 | $25.72 |
| Dexamethasone Sodium Phosphate Generic | 13 | 14 | Under 11 | $29.38 |
| Bicalutamide Generic | 13 | 21 | Under 11 | $370 |
| Exemestane Generic | 12 | 19 | Under 11 | $1,699 |
Brand drugs: 313 claims; generic drugs: 349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravin M Rupani $3,713 ($3,713 in general payments such as food, travel and fees) from 41 companies. The largest payer was Novartis Pharmaceuticals Corporation with $302.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $302 |
| Pfizer Inc. PFE | 10 | $240 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $235 |
| Celgene Corporation BMY | 11 | $219 |
| GlaxoSmithKline, LLC. GSK | 10 | $213 |
| Abbvie Inc. ABBV | 11 | $192 |
| Seagen Inc. PFE | 2 | $182 |
| Merck Sharp & Dohme LLC MRK | 6 | $170 |
| Daiichi Sankyo Inc. 4568.T | 6 | $151 |
| Incyte Corporation INCY | 7 | $146 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.